| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 11.800 | 20140331, Rockmann H
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2013 | Poland | IgE | 212 | 20.800 | 20130424, Kaczmarski M
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 5.710 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 5.710 | 20130111, Ott H
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.000 | 20130912, Lacerda Araujo LM
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Poland | IgE | 79 | 26.200 | 20130424, Kaczmarski M
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 1.300 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 2.860 | 20130605, Simon D
| | 3.2.1 - Source Sensitized (IgE) | 2013 | United States | IgE | 34 | 2.940 | 20130409, Kennedy JL
| | 1.4 - Respiratory Symptoms, Diagnosed | 2012 | Italy | IgE | 755 | 0.260 | 20120821, Liccardi G
| | 3.2.1 - Source Sensitized (IgE) | 2012 | Taiwan | IgE | 190 | 40.530 | 20121008, Chen FM
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 7.070 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 3.700 | 20110223, De Knop KJ
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2012 | France | IgE | 10 | 100.000 | 20120910, Bernard H
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 1.000 | 20111214, Zheng YW
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 1.360 | 20100301, Scala E
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2010 | Japan | IgE | 115 | 46.600 | 20100309, Nakano T
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 3.488 | 20101214, Gadisseur R
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Austria / Germany / Spain / Italy / France | IgE | 78 | 51.300 | 20100923, Hochwallner H
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Spain | IgE | 67 | 83.580 | 20100412, Ibero M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Spain | SPT | 67 | 53.730 | 20100412, Ibero M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy | IgE | 58 | 46.520 | 20100716, DUrbano LE
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Germany | IgE | 66 | 56.700 | 20090520, Schulmeister U
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 2.702 | 20090826, Ebo DG
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 4.550 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 10.000 | 20091005, Ott H
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2009 | Portugal | IgE | 17 | 76.470 | 20090910, Sokolova A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Netherlands | IgE | 18 | 72.220 | 20080401, Lam HY
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2008 | Netherlands | IgE | 13 | 38.460 | 20080401, Lam HY
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2008 | Netherlands | SPT | 11 | 27.270 | 20080401, Lam HY
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Netherlands | SPT | 6 | 50.000 | 20080401, Lam HY
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2006 | Spain | IgE | 234 | 79.000 | 20060407, Martorell A
| | 6.4 - General Population (Aged) | 2006 | Hungary | IgE | 109 | 8.300 | 20060731, Bakos N
| | 5.1.1 - Source Exposed (Symptoms) | 2006 | Italy | SPT | 99 | 74.700 | | | 5.1.1 - Source Exposed (Symptoms) | 2006 | Italy | IgE | 91 | 69.200 | | | 1.5 - Atopic Dermatitis, Diagnosed | 2006 | Spain | IgE | 68 | 48.500 | 20060324, Kendler M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2005 | United States | IgE | 2005 | 75.200 | 20050605, Shek LP
| | 6.3 - General Population (Children) | 2005 | Italy | IgE | 258 | 8.100 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2004 | Italy | SPT | 21 | 90.500 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2004 | Italy | IgE (IB) | 20 | 90.000 | | | 5.1.1 - Source Exposed (Symptoms) | 2003 | Italy | SPT | 24 | 58.300 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2003 | Italy | SPT | 18 | 83.300 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2002 | Italy | IgE | 20 | 65.000 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2002 | Italy | SPT | 20 | 75.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1999 | France | IgE | 92 | 63.000 | | | 5.1.1 - Source Exposed (Symptoms) | 1998 | France | IgE | 92 | 63.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1996 | Argentina | IgE | 80 | 100.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1996 | Argentina | IgE (IB) | 80 | 100.000 | |
|
Loading...
Bos d 8
Homo sapiens
